P401: INNOVATIVE REDUCED-DOSE CHEMOTHERAPY FOLLOWED BY BLINATUMOMAB INDUCTION THERAPY FOR SUCCESSFUL MANAGEMENT OF TREATMENT NAIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA ADULTS: A MULTICENTER, REAL-WORLD STUDY

التفاصيل البيبلوغرافية
العنوان:	P401: INNOVATIVE REDUCED-DOSE CHEMOTHERAPY FOLLOWED BY BLINATUMOMAB INDUCTION THERAPY FOR SUCCESSFUL MANAGEMENT OF TREATMENT NAIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA ADULTS: A MULTICENTER, REAL-WORLD STUDY
المؤلفون:	Jing Lu, Huifen Zhou, Xin Zhou, Yonggong Yang, Laigen Tong, Miao Miao, Xiaofei Yang, Suning Chen
المصدر:	HemaSphere, Vol 7, p e209492b (2023)
بيانات النشر:	Wiley, 2023.
سنة النشر:	2023
المجموعة:	LCC:Diseases of the blood and blood-forming organs
مصطلحات موضوعية:	Diseases of the blood and blood-forming organs, RC633-647.5
نوع الوثيقة:	article
وصف الملف:	electronic resource
اللغة:	English
تدمد:	2572-9241
Relation:	http://journals.lww.com/10.1097/01.HS9.0000968512.20949.2b; https://doaj.org/toc/2572-9241
DOI:	10.1097/01.HS9.0000968512.20949.2b
URL الوصول:	https://doaj.org/article/c6a9bc8f1f45419ab3ca50dbc4ba9672
رقم الأكسشن:	edsdoj.6a9bc8f1f45419ab3ca50dbc4ba9672
قاعدة البيانات:	Directory of Open Access Journals

الوصف
تدمد:	25729241
DOI:	10.1097/01.HS9.0000968512.20949.2b